Completed PHASE2 INTERVENTIONAL 2-arm NCT01172288

N-acetylcysteine (NAC) for Children With Tourette Syndrome

Double-Blind, Placebo-Controlled Trial of N-acetylcysteine (NAC) for the Treatment of Children With Tourette Syndrome

Sponsor: American Academy of Child Adolescent Psychiatry.

Interventions N-Acetylcysteine (NAC) Placebo

Updated 5 times since 2017 Last updated: Dec 19, 2016 Started: Jul 31, 2010 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01172288, this PHASE2 trial focuses on Tic and Tourettes Syndrome and remains completed. Sponsored by American Academy of Child Adolescent Psychiatry., it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Academy of Child Adolescent Psychiatry.
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States